Cassava Sciences, Inc. (FLNA) vs 4D pharma PLC Sponsored ADR (LBPS)

Cassava Sciences, Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. Cassava Sciences, Inc. and 4D pharma PLC Sponsored ADR are of similar size ($37.8M and $37.2M). Cassava Sciences, Inc. has the higher net margin (0.00% vs −9,577.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Cassava Sciences, Inc. leads on 6 and 4D pharma PLC Sponsored ADR on 5.

Valuation

Metric FLNA LBPS Biotechnology median
P/E n/m n/m 7.88
P/S n/m 211.23 11.47
P/B 0.57 9.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.03 n/m 0.74
EV/Sales n/m 205.89 10.73
Earnings yield (116.00%) (40.76%) (28.84%)
Free cash flow yield (81.04%) (30.32%) (23.03%)

Profitability

Metric FLNA LBPS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (9,577.06%) 0.00%
Free cash flow margin 0.00% (6,318.73%) 0.00%
Return on equity (55.78%) (742.15%) (57.72%)
Return on assets (35.34%) (371.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FLNA LBPS Biotechnology median
Revenue growth (TTM) 277.58% — 5.64%
EPS growth (last fiscal year) (259.95%) 35.04% —
Revenue growth, 5-year CAGR — 21.70% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLNA LBPS Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 2.08 5.21 4.73
Net debt to EBITDA 1.01 0.23 0.96

Dividend

Metric FLNA LBPS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FLNA LBPS Biotechnology median
Market cap 37.79m 37.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack